The results of a study published online on March 30th 2010 could very well present a treatment dilemma in OA patients with concomitant osteoporosis.
How to insure target tissue specific outcome for Ca++ supplementation therapy in these type of patients? I certainly am no expert when it comes to supplements, are there any other supplements that could be coupled with the Ca++ in order to at least maximize osseous uptake while also decreasing cartilaginous uptake?
Abstract is available here which includes a link to the complete article as a provisional PDF.
.
” I certainly am no expert when it comes to supplements, are there any other supplements that could be coupled with the Ca++ in order to at least maximize osseous uptake while also decreasing cartilaginous uptake?”
This sounds like a question for the folks at Metagenics Functional Medicine Research Center. Every time I ask them a question, I get a detailed answer within days.